enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: 10-K
Filing Date: 22 Dec 2025Report Date: 31 Oct 2025
Accepted: 22 Dec 2025 07:11 p.m.
Accession Number: 0001193125-25-328743
File Number: 001-41854
Film Number: 251592563
Documents
Primary Document: 10-K
Accepted: 22 Dec 2025 07:11 p.m.
0001193125-25-328743-index-headers.html
Last Modified: 22 Dec 2025 02:11 p.m.
0001193125-25-328743-index.html
Last Modified: 22 Dec 2025 02:11 p.m.
0001193125-25-328743-xbrl.zip
Last Modified: 22 Dec 2025 02:11 p.m.
0001193125-25-328743.txt
Last Modified: 22 Dec 2025 02:11 p.m.
FilingSummary.xml
Last Modified: 22 Dec 2025 02:11 p.m.
MetaLinks.json
Last Modified: 22 Dec 2025 02:11 p.m.
R1.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R10.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R11.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R12.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R13.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R14.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R15.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R16.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R17.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R18.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R19.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R2.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R20.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R21.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R22.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R23.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R24.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R25.htm
Last Modified: 22 Dec 2025 02:11 p.m.
R26.htm
Last Modified: 22 Dec 2025 02:11 p.m.